DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Renvela (Sevelamer Carbonate) - Current Clinical Trials

 
 



Renvela Related Clinical Trials

Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients [Recruiting]

The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan [Recruiting]

Sevelamer for Reducing Endotoxemia and Immune Activation [Completed]

A Phase 1 Study to Examine the Effect of Renvela on the Pharmacodynamics of AZD1722 [Completed]

Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis [Completed]

FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease [Completed]

A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis [Terminated]

An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Patients With Chronic Kidney Disease [Completed]

An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD Patients [Completed]

The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Healthy Volunteers [Completed]

Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD) [Withdrawn]

Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer HCl Tablets in Haemodialysis Patients [Completed]

Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis [Completed]

Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease [Completed]

Sevelamer Hydrochloride in Peritoneal Dialysis Patients [Active, not recruiting]

Comparing Absorption of Dietary Phosphorus When Administering FOSRENOLŽ or RENVELAŽ in Healthy Adult Volunteers [Completed]

CARE-2 (Calcium Acetate [PhosLoŽ]/Sevelamer[RenagelŽ] Evaluation Study 2) for Heart Calcification in Dialysis Patients [Completed]

A Multicenter, Active and Placebo-controlled Study of Enteric Coated Sevelamer in Patients With Mild to Moderate Hypercholesteremia [Completed]

Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD) [Completed]

Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney Disease [Completed]

An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis [Completed]

The Effects of Sevelamer Carbonate on Diabetic Nephropathy [Completed]

Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4 [Recruiting]

Sevelamer in Proteinuric CKD [Recruiting]

Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients [Completed]

Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis [Completed]

Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients [Active, not recruiting]

Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate [Not yet recruiting]

Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy [Completed]

A Phase 1 Multiple Dose Study to Compare the Effects of AMG 223 and Sevelamer HCL (RenagelŽ) [Completed]

Study of Safety and Efficacy of RenagelŽ Compared With Calcium Acetate in Patients With Peritoneal Dialysis [Completed]

Sevelamer Hydrochloride and Femoral and Carotid Intima Media Thickness Progression in End Stage Renal Disease [Completed]

Head to Head Study Against Sevelamer Hydrochloride [Completed]

FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease [Recruiting]

Cross-Over Study of Sevelamer Hydrochloride and Sevelamer Carbonate [Completed]

Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride [Terminated]

Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis [Completed]

A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis [Completed]

Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer Dosing [Completed]

A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD [Completed]

Effect of Bile Acid Secretion and Sequestration on GLP-1 Secretion [Recruiting]

Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2) [Recruiting]

Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney Disease [Recruiting]

Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1) [Recruiting]

Effect of Sevelamer on P-cresol Levels in CKD [Recruiting]

Sevelamer, Fetuin-A and Endothelial Dysfunction in CKD [Completed]

Regulation of Bone Formation in Renal Osteodystrophy [Completed]

Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis [Completed]

Dialysis Clinical Outcomes Revisited (DCOR) Trial [Completed]

Effect of Bile Acid Sequestration on Postprandial GLP-1 Secretion, Glucose Homeostasis and Gut Microbiota [Recruiting]

A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis [Completed]

Reduce Cardiovascular Calcifications to Reduce QT Interval in Dialysis [Completed]

Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease [Completed]

A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis [Completed]

A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients [Completed]

A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients [Completed]

Study of Phosphate Levels in Patients With Chronic Kidney Disease [Completed]

Treatment of Early Stage Renal Failure With Active Vitamin D or a Phosphate Binder. [Completed]

A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia [Completed]

Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia [Completed]

A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia [Completed]

Ferric Citrate in Patients With End-Stage Renal Disease on Dialysis [Completed]

Optimal Anemia Treatment in End Stage Renal Disease (ERSD) [Not yet recruiting]

How Bone is Made in Children Receiving Dialysis [Recruiting]

Hypophosphatemic Rickets in Norway [Active, not recruiting]

Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals [Completed]

A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia [Completed]

A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease [Completed]

Pulmonary Hypertension Prevention in Hemodialysis [Not yet recruiting]

A Study of HS219 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia [Completed]

Subtotal Parathyroidectomy or Total Parathyroidectomy With Autograft in Chronic Kidney Disease Patients Under Dialysis [Recruiting]

Efficacy of Phosphate Binding in Healthy Volunteers: Chewed Versus Crushed Lanthanum Carbonate [Completed]

PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEs [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017